Erratum to: Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study

Pituitary. 2015 Jun;18(3):395-6. doi: 10.1007/s11102-014-0628-z.
No abstract available

Publication types

  • Published Erratum